Skip to main content

Susana Otero Romero

-

Institutions of which they are part

Head of group
Epidemiology and Public Health
Vall Hebron Institut de Recerca
Allergology
General Hospital

Susana Otero Romero

Institutions of which they are part

Head of group
Epidemiology and Public Health
Vall Hebron Institut de Recerca
Allergology
General Hospital

-

-

Projects

Measuring brand-specific influenza vaccine effectiveness

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Cristina Andrés Vergés
Funding agency: The Innovative Medicines Initiative
Funding: 69562.5
Reference: DRIVE_S.OTERO_IMI_2019
Duration: 24/10/2019 - 24/10/2020

Estudio de comorbilidad y de inmunogenicidad vacunal en una cohorte prospectiva de pacientes con primeros brotes sugestivos de Esclerosis Múltiple

IP: Susana Otero Romero
Collaborators: Sonia Maria Uriona Tuma, Estudio de comorbilidad y de inmunogenicidad vacunal en una cohorte prospectiva de pacientes con primeros brotes sugestivos de E, Mar Tintore Subirana, Laia Pinos Tella, Luciana Midaglia Fernandez
Funding agency: Instituto de Salud Carlos III
Funding: 105270
Reference: PI19/01606
Duration: 01/01/2020 - 30/06/2024

Development of Robust and Innovative Vaccine Effectiveness (DRIVE)

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Arnau Peñalver Piñol, Cristina Andrés Vergés
Funding agency: The Innovative Medicines Initiative
Funding: 59690
Reference: DRIVE_S.OTERO_IMI_2018
Duration: 07/08/2018 - 30/09/2019

PILOT PROJECT FOR THE SCREENING OF CHAGAS DISEASE IN COMMUNITY PHARMACIES

IP: Ines Mercedes Oliveira Souto
Collaborators: Susana Otero Romero, Israel Molina Romero, Fernando M Salvador Velez, Jordi Gómez i Prat, PILOT PROJECT FOR THE SCREENING OF CHAGAS DISEASE IN COMMUNITY PHARMACIES, Elena Sulleiro Igual
Funding agency: Fundació La Marató de TV3
Funding: 121150
Reference: 20182610
Duration: 10/05/2019 - 31/01/2023

Related news

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

The Lancet Neurology publishes the new criteria, the result of a global expert consensus led by Dr Xavier Montalban.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Blanca Angélica Urban Vargas

Blanca Angélica Urban Vargas

Predoctoral researcher
Translational Immunology
Read more
Paula García Valentin

Paula García Valentin

Predoctoral researcher
Ophtalmology
Read more
Marc Tort Lacambra

Marc Tort Lacambra

Predoctoral researcher
Ophtalmology
Read more
Carme Garcia Esquerda

Carme Garcia Esquerda

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.